Preparation of chitosan‐nanohydroxyapatite composite scaffolds by a supercritical CO2 assisted process

In this study, chitosan‐nanohydroxyapatite composite scaffolds were prepared by a supercritical fluid assisted process. For this purpose, different amounts of nanohydroxyapatite particles, that is, 0.25, 0.50, and 1.00 wt% were added to chitosan (deacetylation degree: DD 75–85%) solution (2%, w/v, in acetic acid). The gels were then frozen at −20°C, treated in acetone and dried in a supercritical fluid extractor under a constant CO₂ flow of 15 g/min at 35°C and 200 bar for 5 h to obtain porous scaffolds. Scanning electron microscope views showed that the drying of gels under supercritical CO₂ lead to the formation of microporous scaffolds with a pore size distribution of 30–150 μm. Addition of nanohydroxyapatite particles did not significantly affect the pore size distribution. Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy and X‐Ray diffraction analyses supported the successful incorporation of nanohydroxyapatite particles in the scaffold. An increase in water uptake and mechanical strength were observed in composite scaffolds. The results obtained from this study indicated that chitosan‐nanohydroxyapatite scaffolds prepared by using supercritical CO₂ shall be considered as a potential candidate for bone tissue engineering applications. POLYM. COMPOS., 2012. © 2012 Society of Plastics Engineers     

Preparation and characterization of collagen‐based composite conduit for peripheral nerve regeneration

Collagen‐based composite nerve conduit scaffold was prepared by freeze‐drying steam‐extrusion method and modified chemically with glutaraldehyde (GTA) by adding chitosan into collagen. Fourier transform infrared spectroscopy showed that the collagen and chitosan are certainly crosslinked through GTA. It was observed under scanning electron microscope that the modified nerve conduit material is a porous three‐dimensional crosslinked structure and the quantity ratio of the collagen to chitosan has influence on the morphology. The cell proliferation experiment results showed that the collagen‐based composite scaffold prompts the adhesion and proliferation of cells, but as the chitosan increasing, the cell proliferation decreased slightly. The swelling property, the collagenase degradation, and the mechanical property of the scaffold are tested at the quantity ratios of collagen to chitosan 4 : 3, 3 : 1, and 4 : 1 and crosslinking time 0.5 and 1.0 h. The experiments show that the stability of the scaffold is enhanced with decreasing the quantity ratio of collagen to chitosan and increasing crosslinking time. Through the experimental investigations, the modifying technique parameters are discussed and the scaffold exhibits better physical and chemical properties at the quantity ratio of collagen to chitosan 3 : 1 and crosslinking time 0.5 h. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

Development of fibrin conjugated chitosan/nano β‐TCP composite scaffolds with improved cell supportive property for bone tissue regeneration

In the present study, an attempt has been made to improve cell supportive property of chitosan/nano beta tri‐calcium phosphate (β‐TCP) composite scaffolds by modification of scaffold surface with fibrin using ethyl‐3‐(3‐dimethylaminopropyl) carbodimide (EDC) as crosslinking agent. The developed fibrin conjugated chitosan/nano β‐TCP composite scaffolds possess desired pore size and porosity in the range of 45–151 µm and 81.4 ± 4.1%, respectively. No significant change in compressive strength of scaffolds was observed before and after fibrin conjugation. The calculated compressive strength of fibrin conjugated and non‐conjugated chitosan/nano β‐TCP scaffolds are 2.71 ± 0.14 MPa and 2.67 ± 0.11 MPa, respectively. Results of cell culture study have further shown an enhanced cell attachment, cell number, proliferation, differentiation, and mineralization on fibrin conjugated chitosan/nano β‐TCP scaffold. The uniform cell distribution over the scaffold surface and cell infiltration into the scaffold pores were assessed by confocal laser scanning microscopy. Furthermore, higher expression of osteogenic specific genes such as bone sialo protein, osteonectin, alkaline phosphatase, and osteocalcin (OC) on fibrin conjugated scaffolds was observed when compared to scaffolds without fibrin. Altogether, results indicate the potentiality of developed fibrin conjugated composite scaffolds for bone tissue engineering applications. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2015 , 132, 41534.     

Surface treatment with amino acids of porous collagen based scaffolds to improve cell adhesion and proliferation

The purpose of this study was to improve the biocompatibility of glutaraldehyde (GA) cross‐linked chitosan coated collagen scaffold for cartilage tissue regeneration. In order to prevent the potential toxicity of GA, we treated the designed scaffold with either glutamic acid or glycine. Amino acid treated scaffolds were characterized by scanning electron microscopy (SEM) techniques. Afterward, chondrocyte interaction with the composite scaffold was investigated assessing cell adhesion and proliferation using Hoechst staining and MTT cell proliferation assay, respectively. The SEM analyses of the scaffolds’ surface and cross‐section confirmed the adhesion of amino acids on the surface of the scaffolds. We also observed that scaffolds’ porosity was reduced due to the coverage of the pores by chitosan and amino acids, leading to low porosity. The use of amino acid improved the chondrocyte adhesion and proliferation inside the scaffolds’ pores when cells were cultured onto the chitosan‐coated collagen scaffolds. Overall, our in vitro results suggest the use of amino acid to improve the biocompatibility of natural polymer composite scaffold being crosslinked with glutaraldehyde. Such scaffold has improved mechanical properties; biocompatibility thus may be useful for tissue regeneration such as cartilage.

     

Bone morphogenetic protein‐2 immobilization on porous PCL‐BCP‐Col composite scaffolds for bone tissue engineering

The objective of this study was to develop novel porous composite scaffolds for bone tissue engineering through surface modification of polycaprolactone–biphasic calcium phosphate‐based composites (PCL–BCP). PCL–BCP composites were first fabricated with salt‐leaching method followed by aminolysis. Layer by layer (LBL) technique was then used to immobilize collagen (Col) and bone morphogenetic protein (BMP‐2) on PCL–BCP scaffolds to develop PCL–BCP–Col–BMP‐2 composite scaffold. The morphology of the composite was examined by scanning electron microscopy (SEM). The efficiency of grafting of Col and BMP‐2 on composite scaffold was measured by X‐ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FTIR). Both XPS and FTIR confirmed that Col and BMP‐2 were successfully immobilized into PCL–BCP composites. MC3TC3‐E1 preosteoblasts cells were cultivated on composites to determine the effect of Col and BMP‐2 immobilization on cell viability and proliferation. PCL–BCP–Col–BMP‐2 showed more cell attachment, cell viability, and proliferation bone factors compared to PCL–BCP‐Col composites. In addition, in vivo bone formation study using rat models showed that PCL–BCP–Col–BMP‐2 composites had better bone formation than PCL–BCP‐Col scaffold in critical size defect with 4 weeks of duration. These results suggest that PCL–BCP–Col–BMP‐2 composites can enhance bone regeneration in critical size defect in a rat model with 4 weeks of duration. © 2017 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2017 , 134, 45186.     

Silk fibroin‐chondroitin sulfate‐alginate porous scaffolds: Structural properties and in vitro studies

The development of porous biodegradable scaffolds is of great interest in tissue engineering. In this regard, exploration of novel biocompatible materials is needed. Silk fibroin‐chondroitin sulfate‐sodium alginate (SF‐CHS‐SA) porous hybrid scaffolds were successfully prepared via lyophilization method and crosslinked by 1‐ethyl‐3‐(3‐dimethylaminopropyl)carbodiimide‐ethanol treatment. According to the scanning electron microscopy studies, mean pore diameters of the scaffolds were in the range of 60–187 μm. The porosity percentage of the scaffold with SF‐CHS‐SA ratio of 70 : 15 : 15 (w/w/w %) was 92.4 ± 3%. Attenuated total reflectance Fourier transform infrared spectroscopy, X‐ray diffraction, and differential scanning calorimetry results confirmed the transition from amorphous random coil to crystalline β‐sheet in treated SF‐CHS‐SA scaffold. Compressive modulus was significantly improved in hybrid scaffold with SF‐CHS‐SA ratio of 70 : 15 : 15 (3.35 ± 0.15 MPa). Cytotoxicity assay showed that the scaffolds have no toxic effects on chondrocytes. Attachment of chondrocytes was much more improved within the SF‐CHS‐SA hybrid scaffold. Real‐time polymerase chain reaction analyses showed a significant increase in gene expression of collagen type II, aggrecan, and SOX9 and decrease in gene expression of collagen type I for SF‐CHS‐SA compared with SF scaffold. This novel hybrid scaffold can be a good candidate to be utilized as an efficient scaffold for cartilage tissue engineering. © 2014 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014 , 131, 41048.     

Bioactive monetite‐containing whisker‐like fibers reinforced chitosan scaffolds

The aim of this work was to develop bioactive chitosan scaffolds reinforced with monetite‐containing whisker‐like fibers. The fibers synthesized by homogeneous precipitation were characterized as monetite/hydroxyapatite short fibers (MAFs), using XRD, FTIR and SEM. The pure chitosan and MAFs/chitosan composite scaffolds were produced by freeze‐drying, and characterized with respect to porosity, pore size, swelling behavior, compressive strength and modulus, and in vitro bioactivity. The incorporation of MAFs in chitosan matrices led to increase the pore size, according to the evaluation by FE‐SEM, and decrease the porosity of composite scaffolds. The swelling ratio decreased as MAFs content of scaffolds increased. The compressive strength and modulus of scaffolds were improved by an increase in MAFs content. The noncross‐linked scaffolds with a chitosan: MAFs weight ratio of 1:1 (CW3) showed a porosity of 75.5%, and the strength and modulus of 259 kPa and 2.8 MPa in dry state, respectively. The crosslinking by glutaraldehyde resulted in improved mechanical properties. The strength and modulus of cross‐linked CW3 scaffolds in wet state reached to 345 kPa and 1.8 MPa, respectively. The in vitro bioactivity of the reinforced scaffolds, evaluated by FE‐SEM/EDS, XRD, and ATR‐FTIR, was confirmed by the formation of a carbonated apatite layer on their surfaces when they soaked in simulated body fluid (SBF). The results of this initial study indicate that the monetite‐containing whisker‐like fibers may be an appropriate reinforcement of chitosan scaffolds.     

Bone‐like apatite‐coated chitosan scaffolds: Characterization and osteoblastic activity

In this study, porous scaffolds were prepared from chitosan (2% w/v in acetic acid and deacetylation degree: DD > 85%) by freeze‐drying method, and freshly lyophilized scaffolds were stabilized with ethanol solutions. Bone‐like apatite formation on chitosan scaffolds was achieved by immersing the scaffolds into a novel concentrated simulated body fluid (10× SBF‐like solution) for different periods, i.e., 6 and 24 h. Scanning electron microscope views showed that the 6‐h treatment in 10× SBF‐like solution led to the formation of calcium phosphate nucleation sites on chitosan scaffolds, whereas the apatite particles showed characteristic cauliflower‐like morphology at the end of 24‐h treatment. X‐ray diffraction results supported the fact that mineral phase was made of hydroxyapatite. Osteogenic activities of untreated and SBF‐treated chitosan scaffolds were examined by preosteoblastic MC3T3 cell culture studies. The mitochondrial activity test showed that apatite‐coated scaffolds stimulated cell proliferation compared with uncoated scaffolds. Alkaline phosphatase and osteocalcine levels indicated that the differentiation of the cells on all scaffolds increased significantly from 15th day of culture to the 21th day of culture, especially for the cells on 24‐h SBF‐treated scaffolds. The results of this study indicated that 10× SBF‐like solution‐treated chitosan scaffolds may be evaluated for bone tissue engineering. POLYM. COMPOS., 31:1418–1426, 2010. © 2009 Society of Plastics Engineers     

Synthesis and characterization of a novel freeze‐dried silanated chitosan bone tissue engineering scaffold reinforced with electrospun hydroxyapatite nanofiber

Novel chitosan scaffolds containing different weight ratios of electrospun hydroxyapatite nanofibers (n‐HAs) were fabricated. The fibers possessed diameters in the range 110–170 nm. A fixed concentration of glycidyloxypropyl‐trimethoxysilane (GPTMS) as a crosslinking agent was added to the chitosan solution (CG). The porosity percentage was increased when GPTMS and n‐HAs were added to the chitosan structure. The presence of GPTMS in the chitosan structure caused a decrease in the average pore size. The pores were more irregular in shape than pure chitosan and CG scaffolds when n‐HAs were added. A uniform distribution of n‐HAs was seen for a chitosan‐GPTMS hybrid scaffold containing 25 wt% n‐HAs (CGH25) using energy dispersive X‐ray spectroscopy and mapping. The best values of compressive strength and elastic modulus were achieved for CGH25. The swelling ratio was decreased on adding GPTMS to the chitosan scaffold. Different morphologies of hydroxyapatite deposits on the surface of CG and CGH25 (string‐like versus needle‐like precipitates) were observed after 14 days of soaking in simulated body fluid. For CGH25, the viability of MG‐63 osteoblastic cells improved with respect to CG for up to 72 h of cell culture. These results reveal the potential of the chitosan‐CGH25 scaffold for use in bone tissue engineering. © 2019 Society of Chemical Industry     

Influence of the critical concentration parameters on the morphology of chitosan scaffolds for chondrocyte culture

Chitosan‐based membranes are widely investigated as scaffolds for tissue engineering applications, due to the biochemical and structural similarities between chitosan and the components of extracellular matrix. The morphological characteristics of the scaffolds, which determine the cells viability, are highly dependent on their preparation technique. This research compares chondrocytes viability seeded on chitosan scaffolds obtained from two different fabrication techniques: leaching out a porogenic agent and freeze‐gelation. Because these techniques are based on chitosan solutions, the critical overlap and entanglement concentrations are important parameters to be identified and thus the dilute and concentrated regimes were calculated from rheological data. Hence, scaffolds were prepared from chitosan solutions at two concentration regimes, leading us to conclude that chitosan concentration in solution affected the final morphology of the scaffold. The preparation techniques that were used yielded scaffolds with adequate porosity to permit cell adhesion as was observed by scanning electronic microscopy, as well as good mechanical strength to support them measured by dynamic mechanical analysis. The histochemical results obtained after the chondrocytes culture assay showed that scaffolds within a three dimensional structure promoted a higher cell adherence and growth. POLYM. ENG. SCI., 2012. © 2012 Society of Plastics Engineers     

In vitro bone engineering based on polycaprolactone and polycaprolactone–tricalcium phosphate composites

The filling of bone defects in load‐bearing areas requires scaffolds possessing physical properties that are in the range of those of the host bone. In this report, composite scaffolds comprising medical‐grade polycaprolactone and tricalcium phosphate (mPCL‐TCP) (80:20), which have been designed for load‐bearing applications, are characterized and compared with mPCL scaffolds, using in vitro studies. The composite scaffolds exhibited improved hydrophilicity, compressive modulus and strength. Human alveolar osteoblasts (AOs) grown on the composite achieved higher seeding efficiencies and more uniform distribution when compared with mPCL preparations alone. AOs demonstrated better proliferation, denser multilayered cell‐sheets and showed earlier expression of bone matrix‐related proteins on the composite than on mPCL during 28 days in vitro culture. The calcium content in the media decreased in both scaffold/cell constructs. Alkaline phosphatase activity increased significantly in mPCL matrices after osteogenic induction but no distinct change was observed in the composite. Osteocalcin expression was down‐regulated by induction in the composite but was up‐regulated in mPCL at both RNA and protein level. Immuno‐reactive signals for osteopontin and collagen type I, in combination with mineral nodules were found to be stronger in mPCL‐TCP scaffolds. We conclude that the composite scaffolds were more hydrophilic and had improved mechanical properties over mPCL scaffolds. Moreover, the primary AOs achieved better cell proliferation, and showed earlier and different matrix protein expression patterns on the composite scaffolds than on the mPCL scaffolds. Copyright © 2006 Society of Chemical Industry     

Integrated three‐dimensional fiber/hydrogel biphasic scaffolds for periodontal bone tissue engineering

Combining a tissue engineering scaffold made of a load‐bearing polymer with a hydrogel represents a powerful approach to enhancing the functionalities of the resulting biphasic construct, such as its mechanical properties or ability to support cellular colonization. This research activity was aimed at the development of biphasic scaffolds through the combination of an additively manufactured poly(?‐caprolactone) (PCL) fiber construct and a chitosan/poly(γ‐glutamic acid) polyelectrolyte complex hydrogel. By investigating a set of layered structures made of PCL or PCL/hydroxyapatite composite, biphasic scaffold prototypes with good integration of the two phases at the macroscale and microscale were developed. The biphasic constructs were able to absorb cell culture medium up to 10‐fold of their weight, and the combination of the two phases had a significant influence on compressive mechanical properties compared with hydrogel or PCL scaffold alone. In addition, due to the presence of chitosan in the hydrogel phase, biphasic scaffolds exerted a broad‐spectrum antibacterial activity. The developed biphasic systems appear well suited for application in periodontal bone regenerative approaches in which a biodegradable porous structure providing mechanical stability and a hydrogel phase functioning as absorbing depot of endogenous proteins are simultaneously required. © 2016 Society of Chemical Industry     

Surface‐engineered hydroxyapatite nanocrystal/ poly(ε‐caprolactone) hybrid scaffolds for bone tissue engineering

To achieve novel polymer/bioceramic composite scaffolds for use in materials for bone tissue engineering, we prepared organic/inorganic hybrid scaffolds composed of biodegradable poly(ε‐caprolactone) (PCL) and hydroxyapatite (HA), which has excellent biocompatibility with hard tissues and high osteoconductivity and bioactivity. To improve the interactions between the scaffolds and osteoblasts, we focused on surface‐engineered, porous HA/PCL scaffolds that had HA molecules on their surfaces and within them because of the biochemical affinity between the biotin and avidin molecules. The surface modification of HA nanocrystals was performed with two different methods. Using Fourier transform infrared, X‐ray diffraction, and thermogravimetric analysis measurements, we found that surface‐modified HA nanocrystals prepared with an ethylene glycol mediated coupling method showed a higher degree of coupling (%) than those prepared via a direct coupling method. HA/PCL hybrid scaffolds with a well‐controlled porous architecture were fabricated with a gas‐blowing/particle‐leaching process. All HA/PCL scaffold samples exhibited approximately 80–85% porosity. As the HA concentration within the HA/PCL scaffolds increased, the porosity of the HA/PCL scaffolds gradually decreased. The homogeneous immobilization of biotin‐conjugated HA nanocrystals on a three‐dimensional, porous scaffold was observed with confocal microscopy. According to an in vitro cytotoxicity study, all scaffold samples exhibited greater than 80% cell viability, regardless of the HA/PCL composition or preparation method. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2011     

Preparation and cell compatibility evaluation of chitosan/collagen composite scaffolds using amino acids as crosslinking bridges

In this study, a novel freeze‐gelation method instead of the conventional freeze‐drying method was used to fabricate porous chitosan/collagen‐based composite scaffolds for skin‐related tissue engineering applications. To improve the performance of chitosan/collagen composite scaffolds, we added 1‐ethyl‐3‐(3‐dimethylaminopropyl)‐carbodiimide (EDC) and amino acids (including alanine, glycine, and glutamic acid) in the fabrication procedure of the composite scaffolds, in which amino acid molecules act as crosslinking bridges to enhance the EDC‐mediated crosslinking. This novel combination enhanced the tensile strength of the scaffolds from 0.70 N/g for uncrosslinked scaffolds to 2.2 N/g for crosslinked ones; the crosslinked scaffolds also exhibited slower degradation rates. The hydrophilicity of the scaffolds was also significantly enhanced by the addition of amino acids to the scaffolds. Cell compatibility was demonstrated by the in vitro culture of human skin fibroblasts on the scaffolds. The fibroblasts attached and proliferated well on the chitosan/collagen composite scaffolds, especially the one with glutamic acid molecules as crosslinking bridges, whereas cells did not grow on the chitosan scaffolds. Our results suggest that the collagen‐modified chitosan scaffolds with glutamic acid molecules as crosslinking bridges are very promising biomaterials for skin‐related tissue engineering applications because of their enhanced tensile strength and improved cell compatibility with skin fibroblasts. © 2007 Wiley Periodicals, Inc. J Appl Polym Sci, 2007     

Fabrication and characterization of natural origin chitosan‐ gelatin‐alginate composite scaffold by foaming method without using surfactant

A natural origin tripolymer scaffold from chitosan, gelatin, and alginate was fabricated by applying foaming method without adding any foam stabilizing surfactant. Previously, in foaming method of scaffold fabrication, toxic surfactants were used to stabilize the foam, but in this work, the use of surfactant has been avoided strictly, which can provide better environment for cellular response and viability. In foaming method, stable foam is produced simply by agitating the polymer (alginate‐gelatin) solution, and the foam is crosslinked with CaCl₂, glutaraldehyde, and chitosan to produce tripolymer alginate‐gelatin‐chitosan composite scaffold. Microscopic images of the composite scaffold revealed the presence of interconnected pores, mostly spread over the entire surface of the scaffold. The scaffold has a porosity of 90% with a mean pore size of 57 μm. Swelling and degradation studies of the scaffold showed that the scaffold possesses excellent properties of hydrophilicity and biodegradability. In vitro cell culture studies by seeding L929 mouse fibroblast cells on scaffold revealed excellent cell viability, proliferation rate and adhesion as indicated by MTT assay, DNA quantification, and phase contrast microscopy of cell‐scaffold construct. The natural origin composite scaffold fabricated by the simplest method i.e., foaming method, but without adding any surfactant, is cheap, biocompatible, and it might find potential applications in the field of tissue engineering. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013     

Morphology,wettability, and mechanical properties of polycaprolactone/hydroxyapatite composite scaffolds with interconnected pore structures fabricated by a mini‐deposition system

A new mini‐deposition system (MDS) was developed to fabricate scaffolds with interconnected pore structures and anatomical geometry for bone tissue engineering. Polycaprolactone/hydroxyapatite (PCL/HA) composites with varying hydroxyapatite (HA) content were adopted to manufacture scaffolds by using MDS with a porosity of 54.6%, a pore size of 716 μm in the x‐y plane, and 116 μm in the z direction. The water uptake ratio and compressive modulus of PCL/HA composite scaffold increase from 8 to 39% and from 26.5 to 49.8 MPa, respectively, as the HA content increases from 0 to 40%. PCL/HA composite scaffolds have better wettability and mechanical properties than pure PCL scaffold. A PCL/HA composite scaffold for mandible bone repair was successfully fabricated with both interconnected pore structures and anatomical shape to demonstrate the versatility of MDS. POLYM. ENG. SCI., 2012. © 2012 Society of Plastics Engineers     

Electrospun polylactide/silk fibroin–gelatin composite tubular scaffolds for small‐diameter tissue engineering blood vessels

Many synthetic scaffolds have been used as vascular substitutes for clinical use. However, many of these scaffolds may not show suitable properties when they are exposed to physiologic vascular environments, and they may fail eventually because of some unexpected conditions. Electrospinning technology offers the potential for controlling the composition, structure, and mechanical properties of scaffolds. In this study, a tubular scaffold (inner diameter = 4.5 mm) composed of a polylactide (PLA) fiber outside layer and a silk fibroin (SF)–gelatin fiber inner layer (PLA/SF–gelatin) was fabricated by electrospinning. The morphological, biomechanical, and biological properties of the composite scaffold were examined. The PLA/SF–gelatin composite tubular scaffold possessed a porous structure; the porosity of the scaffold reached 82 ± 2%. The composite scaffold achieved the appropriate breaking strength (1.28 ± 0.21 MPa) and adequate pliability (elasticity up to 41.11 ± 2.17% strain) and possessed a fine suture retention strength (1.07 ± 0.07 N). The burst pressure of the composite scaffold was 111.4 ± 2.6 kPa, which was much higher than the native vessels. A mitochondrial metabolic assay and scanning electron microscopy observations indicated that both 3T3 mouse fibroblasts and human umbilical vein endothelial cells grew and proliferated well on the composite scaffold in vitro after they were cultured for some days. The PLA/SF–gelatin composite tubular scaffolds presented appropriate characteristics to be considered as candidate scaffolds for blood vessel tissue engineering. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

Development of a novel glucosamine/silk fibroin–chitosan blend porous scaffold for cartilage tissue engineering applications

Silk fibroin–chitosan blend is reported to be an attractive scaffold material for tissue engineering applications. In our earlier study, we developed a scaffold having an optimal silk fibroin–chitosan blend ratio of 80:20 and proved its potentiality for cartilage tissue engineering applications. Glucosamine is one of the major structural components of cartilage tissue. The present work investigates the effect of glucosamine components on the physicochemical and biocompatibility properties of this scaffold. To this end, varied amounts of glucosamine were added to silk fibroin–chitosan blend with the aim of improving various scaffold properties. The addition of glucosamine components did not show any significant change in physicochemical properties of silk fibroin–chitosan blend scaffolds. The composite scaffold showed an open pore structure with desired pore size and porosity. However, cell culture study using human mesenchymal stem cells derived from umbilical cord blood revealed an overall increase in cell supportive properties of glucosamine-added scaffolds. Cell viability, cell proliferation and glycosaminoglycan assays confirmed enhanced cell viability and proliferation of mesenchymal stem cells. Thus, this study demonstrated the beneficial effect of glucosamine on improving the cell supportive property of silk fibroin–chitosan blend scaffolds making it more potential for cartilage tissue regeneration. To the best of our knowledge, this is the first report on the study of glucosamine-added silk fibroin–chitosan blend porous scaffolds seeded with mesenchymal stem cells derived from umbilical cord blood.     

Biodegradable composite scaffolds of poly(lactic‐co‐glycolic acid) 85:15 and nano‐hydroxyapatite with acidic microclimate controlling additive

The aim of this study was to prepare and characterize biodegradable scaffolds of poly(lactic‐co‐glycolic acid) (PLGA 85:15) and nano‐hydroxyapatite (HA) containing magnesium carbonate (MC) as acidic microclimate controlling additive. Porous and nonporous scaffolds of PLGA 85:15 and nano‐HA containing MC were prepared by solvent casting and particulate leaching method. Scaffolds were degraded at pH 7.4 phosphate buffer for 90 days. At regular intervals, pH of the degradation medium, release of degradation products, mass loss, water sorption, and tensile strength were measured. The results showed that the pH of the degradation medium significantly decreased with control specimens, whereas the scaffolds with MC did not show significant changes. In addition, acidic monomer release from the scaffolds with MC was found to be less, whereas the water sorption was found to be significantly higher. The tensile strength of the scaffold was found to be dependent on the concentration of HA and porosity. These results indicate that incorporation of MC to PLGA 85:15 scaffolds reduces the acidic microclimate with changes in mass loss, water sorption, and strength properties. POLYM. COMPOS., 38:1175–1182, 2017. © 2015 Society of Plastics Engineers     

Preparation and characterization of nanohydroxyapatite strengthening nanofibrous poly(L‐lactide) scaffold for bone tissue engineering

A biomimetic nanofibrous poly(L ‐lactide) scaffold strengthened by nanohydroxyapatite particles was fabricated via a thermally induced phase separation technique. Scanning electron microscopy results showed that nanohydroxyapatite particles uniformly dispersed in the nanofibrous poly(L ‐lactide) scaffold (50–500 nm in fiber diameter) with slight aggregation at a high nHA content, but showed no influence on the interconnected macroporous and nanofibrous structure of the scaffold. The nanofibrous poly(L ‐lactide) scaffold presented a specific surface area of 34.06 m² g^?1, which was much higher than that of 2.79 m² g^?1 for the poly(L ‐lactide) scaffold with platelet structure. Moreover, the specific surface area of the nanofibrous scaffold was further enhanced by incorporating nanohydroxyapatite particles. With increasing the nanohydroxyapatite content, the compressive modulus and amount of bovine serum albumin adsorbed on the surface of the nanofibrous composite scaffold were markedly improved, as opposed to the decreased crystallinity. In comparison to poly(L ‐lactide) scaffold, both the nanofibrous poly(L ‐lactide) and poly(L ‐lactide)/nanohydroxyapatite scaffolds exhibited a faster degradation rate for their much larger specific surface area. The culture of bone mesenchymal stem cell indicated that the composite nanofibrous poly(L ‐lactide) scaffold with 50 wt % nanohydroxyapatite showed the highest cells viability among various poly(L ‐lactide)‐based scaffolds. The strengthened biomimetic nanofibrous poly(L ‐lactide)/nanohydroxyapatite composite scaffold will be a potential candidate for bone tissue engineering. © 2012 Wiley Periodicals, Inc. J. Appl. Polym. Sci., 2013